UK markets closed

Laboratory Corporation of America Holdings (LH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
219.16+1.39 (+0.64%)
At close: 04:00PM EST
224.42 +5.26 (+2.40%)
After hours: 06:21PM EST

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127

IndustryDiagnostics & Research
Full-time employees67,000

Key executives

NameTitlePayExercisedYear born
Mr. Adam H. SchechterPresident, CEO & Chairman3.72MN/A1965
Mr. Glenn A. EisenbergCFO & Executive VP1.54M3.43M1961
Mr. Mark S. SchroederExecutive VP, President of Diagnostics Laboratories & COO1.06MN/A1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVP, President of Early Development Research Laboratories & Chief Medical Officer1.22MN/A1974
Mr. Peter J. WilkinsonSenior VP & Chief Accounting OfficerN/AN/A1972
Mr. Lance V. BerberianExecutive VP and Chief Information & Technology Officer876.62kN/A1963
Dr. Marcia T. Eisenberg Ph.D.Chief Scientific Officer & Senior VPN/AN/A1959
Christin O'DonnellVice President of Investor RelationsN/AN/AN/A
Ms. Sandra D. van der VaartExecutive VP, Chief Legal Officer, Chief Compliance Officer & Corporate SecretaryN/AN/A1960
Ms. Amy B. SummyExecutive VP & Chief Marketing OfficerN/AN/A1967
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Corporate governance

Laboratory Corporation of America Holdings’s ISS governance QualityScore as of 1 February 2024 is 2. The pillar scores are Audit: 5; Board: 7; Shareholder rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.